$PMBS News 10-K: PURAMED BIOSCIENCE - ALERTS, HOT STOCKS & CHARTS

$PMBS News 10-K: PURAMED BIOSCIENCE INC. 4:16 p.m. Oct.

New Post Public Reply Private Reply Replies (0) Message Board

Jan 8, 2014 at 1:09 PM

$PMBS News

10-K: PURAMED BIOSCIENCE INC. 4:16 p.m. Oct. 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: PURAMED BIOSCIENCE INC. 4:25 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
3 Penny Stocks to Watch 11:41 p.m. May 14, 2013 - InvestorPlace.com
10-Q: PURAMED BIOSCIENCE INC. 4:13 p.m. Feb. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)

PuraMed BioScience®, Inc., Launches LipiGesic M Sampling Campaign Targeting Headache Specialists 12:18 p.m. Sept. 25, 2013 - PR Newswire
PuraMed BioScience Invited to Discuss LipiGesic M on Armed Forces Network 11:03 a.m. Aug. 29, 2013 - PR Newswire
PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M 7:00 a.m. Aug. 22, 2013 - PR Newswire
PuraMed BioScience Announces Distributor Agreement with OuterBanks Outdoors 1:08 p.m. Aug. 14, 2013 - PR Newswire
LipiGesic M is the only recommended first-line therapy for acute migraine that has no evidence of rebound headache 2:44 p.m. Aug. 5, 2013 - PR Newswire
PuraMed BioScience Announces Common Shares Outstanding of 42.6 Million 10:27 a.m. July 2, 2013 - PR Newswire
PuraMed BioScience? Announces Science Behind LipiGesic? M Migraine Treatment 10:05 a.m. June 21, 2013 - PR Newswire
PuraMed BioScience? Announces Interview on Big Biz Show Discussing LipiGesic? M 7:00 a.m. June 10, 2013 - PR Newswire
PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition 10:11 a.m. May 30, 2013 - PR Newswire
PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 1:10 p.m. May 23, 2013 - PR Newswire
LipiGesic? M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications 1:33 p.m. May 21, 2013 - PR Newswire
PuraMed BioScience?, Inc., Launches Its Business-to-Business Migraine First Aid Kit(TM) to Promote Workplace Health and Wellness 3:01 p.m. May 15, 2013 - PR Newswire
PuraMed BioScience? Expands International Distribution with Order from Colombia, South America 10:13 a.m. May 13, 2013 - PR Newswire
Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation 8:49 a.m. April 24, 2013 - PR Newswire
PuraMed BioScience® Inc., Announces Manufacturing and Packaging Vendors for LipiGesic® M, its Highly Effective, Non-Prescription Migraine Pain Reliever 7:00 a.m. April 18, 2013 - PR Newswire
PuraMed BioScience to Expand Marketing of Over-the-Counter Migraine Product to Additional National Retail Chains 11:34 a.m. April 12, 2013 - PR Newswire
Reanalysis of Clinical Trial Data Confirms LipiGesic? M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms 1:58 p.m. March 5, 2013 - PR Newswire
PuraMed BioScience?Inc., Manufacturers of LipiGesic? M, Engaged FOCUS LLC, an Investment Banking Firm, to Explore Strategic Alternatives 3:09 p.m. Feb. 26, 2013 - PR Newswire
PuraMed BioScience? Receives Patent Allowance on Over-the-Counter Migraine Pain Reliever, LipiGesic?M 7:00 a.m. Jan. 15, 2013 - PR Newswire

Newer

Older

Top 5 Most Recently Viewed Articles

Navigating Cash Investments in a Shifting Yield Environment

Understanding Recent Trends in the Yield Curve Recent conversations among analysts reveal a careful balance in cash and investment strategies, especially regarding potential interest rate cuts. While some believe these cuts could lead to a shift away from cash-like instruments, the situation is more nuanced. Certain segments of shorter-dated government bonds may take a...

Air Canada Resumes Flights After Government Arbitration Ruling

Air Canada Resumes Operations After Government Decision Air Canada has announced plans to resume flights after receiving a directive from the Canadian Industrial Relations Board (CIRB). This decision follows a government referral of existing contract negotiations between the airline and the Canadian Union of Public Employees (CUPE) to binding arbitration. Details of the...

Prenosis Secures $20M Funding to Elevate Patient Outcomes

Prenosis Secures $20 Million Funding for Diagnostic Innovations In a significant stride towards advancing patient care, Prenosis, a leading biology-based technology firm, announced its successful completion of a $20 million Series A financing round alongside securing a $20 million contract from the Biomedical Advanced Research and Development Authority (BARDA). This dual...

Cherokee Federal Strengthens Security Services with Key Hire

Cherokee Federal Expands Its Team for Enhanced Security Solutions Cherokee Federal, part of Cherokee Nation Businesses, is making significant strides in the federal contracting arena, particularly within the homeland security sector. The growing demand for effective security solutions prompted the company to enhance its capabilities. Recently, Cherokee Federal announced...

China's Economic Strategies Foster Stability and Growth In a recent report, Chinese officials have conveyed their strong confidence in the country's financial market, emphasizing the need for sustained and stable development. This determination reflects the country's proactive measures to adapt to an ever-evolving economic landscape. Government Initiatives to Boost Market...

$PMBS News 10-K: PURAMED BIOSCIENCE INC. 4:16 p.m. Oct.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles